Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Cipla: Sharp improvement in margins not likely to sustain

    While the respiratory portfolio remains a significant part of the US portfolio, the peptides portfolio is a key watch in the near to medium term.

    Anubhav Sahu
    January 27, 2023 / 12:49 IST
    • PRO Panorama

      Moneycontrol Pro Panorama | Hollow markets

      Apr 20, 2026 / 02:33 PM IST

      For this edition of Moneycontrol Pro Panorama: China’s export surge masks underlying economic fragility, Trump’s Iran stance r...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender | Can Trump walk away from the Iran war?

      Apr 4, 2026 / 08:54 AM IST

      While global markets hope for de-escalation, the strategic stakes in the Middle East make a quick exit difficult. Here's what it m...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More